Structure

Physi-Chem Properties

Molecular Weight:  478.22
Volume:  466.74
LogP:  2.052
LogD:  1.556
LogS:  -3.594
# Rotatable Bonds:  3
TPSA:  142.75
# H-Bond Aceptor:  9
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.253
Synthetic Accessibility Score:  6.754
Fsp3:  0.76
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.587
MDCK Permeability:  8.366807014681399e-05
Pgp-inhibitor:  0.764
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.909
20% Bioavailability (F20%):  0.016
30% Bioavailability (F30%):  0.991

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.132
Plasma Protein Binding (PPB):  49.095767974853516%
Volume Distribution (VD):  0.939
Pgp-substrate:  22.65493392944336%

ADMET: Metabolism

CYP1A2-inhibitor:  0.02
CYP1A2-substrate:  0.821
CYP2C19-inhibitor:  0.017
CYP2C19-substrate:  0.54
CYP2C9-inhibitor:  0.006
CYP2C9-substrate:  0.016
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.085
CYP3A4-inhibitor:  0.262
CYP3A4-substrate:  0.189

ADMET: Excretion

Clearance (CL):  3.247
Half-life (T1/2):  0.83

ADMET: Toxicity

hERG Blockers:  0.068
Human Hepatotoxicity (H-HT):  0.818
Drug-inuced Liver Injury (DILI):  0.575
AMES Toxicity:  0.028
Rat Oral Acute Toxicity:  0.715
Maximum Recommended Daily Dose:  0.057
Skin Sensitization:  0.218
Carcinogencity:  0.022
Eye Corrosion:  0.003
Eye Irritation:  0.013
Respiratory Toxicity:  0.969

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473968

Natural Product ID:  NPC473968
Common Name*:   NMMILYGYICKSOQ-HHLMMFKLSA-N
IUPAC Name:   n.a.
Synonyms:   6Alpha-Tigloyloxychaparrin
Standard InCHIKey:  NMMILYGYICKSOQ-HHLMMFKLSA-N
Standard InCHI:  InChI=1S/C25H34O9/c1-6-10(2)21(30)34-17-16-11(3)7-14(26)19(29)23(16,5)22-24-9-32-25(22,31)18(28)12(4)13(24)8-15(27)33-20(17)24/h6-7,12-14,16-20,22,26,28-29,31H,8-9H2,1-5H3/b10-6-/t12-,13+,14+,16-,17-,18-,19-,20-,22-,23-,24-,25+/m1/s1
SMILES:  CC=C(C)C(=O)OC1C2C(=CC(C(C2(C3C45C1OC(=O)CC4C(C(C3(OC5)O)O)C)C)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL456736
PubChem CID:   44584045
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0002119] Quassinoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. xylem n.a. DOI[10.1248/cpb.24.1532]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[22224661]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[22799262]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[23290052]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota stem barks n.a. n.a. PMID[25666824]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO15443 Ailanthus altissima Species Simaroubaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus GI = 0.24 ug ml-1 PMID[533010]
NPT65 Cell Line HepG2 Homo sapiens IC50 > 50000.0 nM PMID[533011]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 10540.0 nM PMID[533011]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 2430.0 nM PMID[533011]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473968 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9636 High Similarity NPC476529
0.9636 High Similarity NPC475775
0.955 High Similarity NPC107338
0.955 High Similarity NPC109607
0.9386 High Similarity NPC470922
0.9346 High Similarity NPC143706
0.9346 High Similarity NPC472534
0.9286 High Similarity NPC122971
0.9273 High Similarity NPC469877
0.9273 High Similarity NPC470919
0.9266 High Similarity NPC302146
0.9189 High Similarity NPC259306
0.9189 High Similarity NPC474046
0.9189 High Similarity NPC470628
0.9182 High Similarity NPC51978
0.9099 High Similarity NPC474906
0.9099 High Similarity NPC18547
0.9091 High Similarity NPC289312
0.9091 High Similarity NPC11252
0.9018 High Similarity NPC152199
0.9018 High Similarity NPC235539
0.9018 High Similarity NPC134869
0.9 High Similarity NPC201992
0.8966 High Similarity NPC67251
0.8938 High Similarity NPC473590
0.8919 High Similarity NPC194951
0.8919 High Similarity NPC269530
0.8919 High Similarity NPC12046
0.8899 High Similarity NPC275539
0.8899 High Similarity NPC189075
0.887 High Similarity NPC112038
0.886 High Similarity NPC297179
0.885 High Similarity NPC474734
0.8839 High Similarity NPC25909
0.8839 High Similarity NPC157441
0.8807 High Similarity NPC110496
0.8793 High Similarity NPC202051
0.8783 High Similarity NPC473636
0.8783 High Similarity NPC77689
0.8772 High Similarity NPC474483
0.8772 High Similarity NPC134430
0.8761 High Similarity NPC472274
0.8729 High Similarity NPC24651
0.8729 High Similarity NPC476729
0.8727 High Similarity NPC293850
0.8716 High Similarity NPC127609
0.8707 High Similarity NPC48692
0.8696 High Similarity NPC204552
0.8696 High Similarity NPC188667
0.8684 High Similarity NPC251236
0.8684 High Similarity NPC268954
0.8684 High Similarity NPC96312
0.8684 High Similarity NPC471816
0.8684 High Similarity NPC40632
0.8684 High Similarity NPC44170
0.8684 High Similarity NPC328374
0.8673 High Similarity NPC264153
0.8673 High Similarity NPC49451
0.8644 High Similarity NPC18945
0.8644 High Similarity NPC265557
0.8644 High Similarity NPC105926
0.8644 High Similarity NPC91693
0.8636 High Similarity NPC230541
0.8632 High Similarity NPC476204
0.8632 High Similarity NPC170084
0.8621 High Similarity NPC469488
0.8621 High Similarity NPC470914
0.8621 High Similarity NPC211093
0.8621 High Similarity NPC475041
0.8621 High Similarity NPC473839
0.8611 High Similarity NPC295791
0.8609 High Similarity NPC13713
0.8609 High Similarity NPC309433
0.8609 High Similarity NPC470775
0.8609 High Similarity NPC176513
0.8609 High Similarity NPC475809
0.8607 High Similarity NPC471855
0.8607 High Similarity NPC478153
0.8607 High Similarity NPC478150
0.8607 High Similarity NPC478152
0.8596 High Similarity NPC181145
0.8596 High Similarity NPC110861
0.8596 High Similarity NPC473798
0.8596 High Similarity NPC243354
0.8584 High Similarity NPC472002
0.8583 High Similarity NPC470780
0.8571 High Similarity NPC5103
0.8571 High Similarity NPC318135
0.8571 High Similarity NPC83005
0.8559 High Similarity NPC269642
0.8559 High Similarity NPC392
0.8559 High Similarity NPC177524
0.8559 High Similarity NPC312833
0.8559 High Similarity NPC219900
0.8559 High Similarity NPC475263
0.8547 High Similarity NPC476150
0.8547 High Similarity NPC470312
0.8547 High Similarity NPC476127
0.8545 High Similarity NPC102352
0.8537 High Similarity NPC478151
0.8534 High Similarity NPC251310
0.8534 High Similarity NPC470776
0.8532 High Similarity NPC254202
0.8525 High Similarity NPC173435
0.8525 High Similarity NPC478065
0.8525 High Similarity NPC25998
0.8525 High Similarity NPC264566
0.8525 High Similarity NPC301639
0.8525 High Similarity NPC478064
0.8525 High Similarity NPC476074
0.8525 High Similarity NPC134914
0.8525 High Similarity NPC329993
0.8525 High Similarity NPC262796
0.8525 High Similarity NPC172374
0.8525 High Similarity NPC478155
0.8525 High Similarity NPC477197
0.8525 High Similarity NPC475167
0.8525 High Similarity NPC475377
0.8525 High Similarity NPC45346
0.8522 High Similarity NPC106228
0.8522 High Similarity NPC138372
0.8512 High Similarity NPC473620
0.8512 High Similarity NPC245094
0.8512 High Similarity NPC311534
0.8509 High Similarity NPC469496
0.8509 High Similarity NPC311592
0.8509 High Similarity NPC75167
0.8509 High Similarity NPC293658
0.8509 High Similarity NPC194273
0.8509 High Similarity NPC469463
0.8509 High Similarity NPC469454
0.8509 High Similarity NPC255017
0.8509 High Similarity NPC474410
0.85 High Similarity NPC293112
0.8496 Intermediate Similarity NPC132790
0.8496 Intermediate Similarity NPC471243
0.8496 Intermediate Similarity NPC474846
0.8496 Intermediate Similarity NPC469655
0.8496 Intermediate Similarity NPC97939
0.8496 Intermediate Similarity NPC247031
0.8496 Intermediate Similarity NPC100329
0.8496 Intermediate Similarity NPC188738
0.8496 Intermediate Similarity NPC469656
0.8487 Intermediate Similarity NPC469789
0.8487 Intermediate Similarity NPC469382
0.8487 Intermediate Similarity NPC27363
0.8482 Intermediate Similarity NPC112457
0.8482 Intermediate Similarity NPC141350
0.8475 Intermediate Similarity NPC102822
0.8475 Intermediate Similarity NPC470779
0.8475 Intermediate Similarity NPC477046
0.8468 Intermediate Similarity NPC187435
0.8468 Intermediate Similarity NPC293512
0.8468 Intermediate Similarity NPC67321
0.8468 Intermediate Similarity NPC3316
0.8468 Intermediate Similarity NPC144854
0.8468 Intermediate Similarity NPC473586
0.8462 Intermediate Similarity NPC9674
0.8462 Intermediate Similarity NPC19028
0.8462 Intermediate Similarity NPC469380
0.8462 Intermediate Similarity NPC477071
0.8455 Intermediate Similarity NPC478154
0.8448 Intermediate Similarity NPC98249
0.8448 Intermediate Similarity NPC470854
0.8448 Intermediate Similarity NPC470171
0.8448 Intermediate Similarity NPC122033
0.8448 Intermediate Similarity NPC53396
0.8448 Intermediate Similarity NPC97908
0.8448 Intermediate Similarity NPC474654
0.8448 Intermediate Similarity NPC469684
0.8448 Intermediate Similarity NPC287343
0.8448 Intermediate Similarity NPC473405
0.8448 Intermediate Similarity NPC284068
0.8443 Intermediate Similarity NPC477077
0.8443 Intermediate Similarity NPC476966
0.8443 Intermediate Similarity NPC477076
0.8443 Intermediate Similarity NPC477079
0.8443 Intermediate Similarity NPC470913
0.8443 Intermediate Similarity NPC477196
0.8443 Intermediate Similarity NPC471407
0.8435 Intermediate Similarity NPC475633
0.8435 Intermediate Similarity NPC102088
0.843 Intermediate Similarity NPC42399
0.8421 Intermediate Similarity NPC90952
0.8421 Intermediate Similarity NPC277769
0.8421 Intermediate Similarity NPC321272
0.8421 Intermediate Similarity NPC174836
0.8421 Intermediate Similarity NPC328074
0.8421 Intermediate Similarity NPC470025
0.8421 Intermediate Similarity NPC474516
0.8421 Intermediate Similarity NPC317460
0.8417 Intermediate Similarity NPC172154
0.8417 Intermediate Similarity NPC469379
0.8417 Intermediate Similarity NPC81736
0.8417 Intermediate Similarity NPC86346
0.8417 Intermediate Similarity NPC8369
0.8417 Intermediate Similarity NPC75856
0.8413 Intermediate Similarity NPC596
0.8413 Intermediate Similarity NPC140045
0.8413 Intermediate Similarity NPC295885

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473968 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8559 High Similarity NPD6686 Approved
0.8347 Intermediate Similarity NPD7507 Approved
0.8145 Intermediate Similarity NPD7319 Approved
0.8 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD4225 Approved
0.7983 Intermediate Similarity NPD7115 Discovery
0.7928 Intermediate Similarity NPD7640 Approved
0.7928 Intermediate Similarity NPD7639 Approved
0.7886 Intermediate Similarity NPD8328 Phase 3
0.7869 Intermediate Similarity NPD8517 Approved
0.7869 Intermediate Similarity NPD8513 Phase 3
0.7869 Intermediate Similarity NPD8515 Approved
0.7869 Intermediate Similarity NPD8516 Approved
0.7851 Intermediate Similarity NPD7516 Approved
0.7845 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7838 Intermediate Similarity NPD7638 Approved
0.7826 Intermediate Similarity NPD6412 Phase 2
0.7778 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7769 Intermediate Similarity NPD7327 Approved
0.7769 Intermediate Similarity NPD7328 Approved
0.7724 Intermediate Similarity NPD8033 Approved
0.7724 Intermediate Similarity NPD7503 Approved
0.7686 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.768 Intermediate Similarity NPD7492 Approved
0.7647 Intermediate Similarity NPD8297 Approved
0.7647 Intermediate Similarity NPD6882 Approved
0.7642 Intermediate Similarity NPD8377 Approved
0.7642 Intermediate Similarity NPD6319 Approved
0.7642 Intermediate Similarity NPD6054 Approved
0.7642 Intermediate Similarity NPD8294 Approved
0.7638 Intermediate Similarity NPD7736 Approved
0.7619 Intermediate Similarity NPD6616 Approved
0.7607 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7583 Intermediate Similarity NPD8133 Approved
0.7583 Intermediate Similarity NPD4632 Approved
0.7581 Intermediate Similarity NPD8378 Approved
0.7581 Intermediate Similarity NPD8380 Approved
0.7581 Intermediate Similarity NPD8296 Approved
0.7581 Intermediate Similarity NPD8335 Approved
0.7581 Intermediate Similarity NPD8379 Approved
0.7559 Intermediate Similarity NPD7078 Approved
0.7541 Intermediate Similarity NPD6009 Approved
0.7523 Intermediate Similarity NPD6698 Approved
0.7523 Intermediate Similarity NPD46 Approved
0.7521 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.752 Intermediate Similarity NPD6370 Approved
0.75 Intermediate Similarity NPD6059 Approved
0.7458 Intermediate Similarity NPD6899 Approved
0.7458 Intermediate Similarity NPD6881 Approved
0.744 Intermediate Similarity NPD6015 Approved
0.744 Intermediate Similarity NPD6016 Approved
0.7436 Intermediate Similarity NPD6402 Approved
0.7436 Intermediate Similarity NPD5739 Approved
0.7436 Intermediate Similarity NPD7128 Approved
0.7436 Intermediate Similarity NPD6675 Approved
0.7422 Intermediate Similarity NPD8074 Phase 3
0.7422 Intermediate Similarity NPD8293 Discontinued
0.7417 Intermediate Similarity NPD8413 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD6650 Approved
0.7417 Intermediate Similarity NPD6649 Approved
0.7395 Intermediate Similarity NPD6373 Approved
0.7395 Intermediate Similarity NPD6372 Approved
0.7391 Intermediate Similarity NPD5344 Discontinued
0.7381 Intermediate Similarity NPD5988 Approved
0.7373 Intermediate Similarity NPD5697 Approved
0.7333 Intermediate Similarity NPD7102 Approved
0.7333 Intermediate Similarity NPD6883 Approved
0.7333 Intermediate Similarity NPD7290 Approved
0.7328 Intermediate Similarity NPD7632 Discontinued
0.7321 Intermediate Similarity NPD7748 Approved
0.7311 Intermediate Similarity NPD7320 Approved
0.7297 Intermediate Similarity NPD7515 Phase 2
0.7288 Intermediate Similarity NPD6008 Approved
0.7281 Intermediate Similarity NPD7902 Approved
0.7273 Intermediate Similarity NPD6617 Approved
0.7273 Intermediate Similarity NPD6869 Approved
0.7273 Intermediate Similarity NPD6847 Approved
0.7273 Intermediate Similarity NPD8130 Phase 1
0.725 Intermediate Similarity NPD6014 Approved
0.725 Intermediate Similarity NPD6013 Approved
0.725 Intermediate Similarity NPD6012 Approved
0.7227 Intermediate Similarity NPD5701 Approved
0.7213 Intermediate Similarity NPD6053 Discontinued
0.7188 Intermediate Similarity NPD7604 Phase 2
0.7179 Intermediate Similarity NPD5211 Phase 2
0.7167 Intermediate Similarity NPD6011 Approved
0.7165 Intermediate Similarity NPD5983 Phase 2
0.7143 Intermediate Similarity NPD6079 Approved
0.7117 Intermediate Similarity NPD5328 Approved
0.7091 Intermediate Similarity NPD3573 Approved
0.708 Intermediate Similarity NPD5778 Approved
0.708 Intermediate Similarity NPD5779 Approved
0.708 Intermediate Similarity NPD6399 Phase 3
0.7077 Intermediate Similarity NPD6336 Discontinued
0.7069 Intermediate Similarity NPD8029 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD7260 Phase 2
0.7059 Intermediate Similarity NPD5141 Approved
0.7049 Intermediate Similarity NPD6371 Approved
0.7049 Intermediate Similarity NPD4634 Approved
0.7031 Intermediate Similarity NPD6921 Approved
0.7018 Intermediate Similarity NPD7900 Approved
0.7018 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7009 Intermediate Similarity NPD6648 Approved
0.7009 Intermediate Similarity NPD5286 Approved
0.7009 Intermediate Similarity NPD4696 Approved
0.7009 Intermediate Similarity NPD5285 Approved
0.6992 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6991 Remote Similarity NPD7983 Approved
0.6991 Remote Similarity NPD6411 Approved
0.6983 Remote Similarity NPD4755 Approved
0.697 Remote Similarity NPD6033 Approved
0.6944 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6942 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6067 Discontinued
0.6909 Remote Similarity NPD1694 Approved
0.6905 Remote Similarity NPD6274 Approved
0.6903 Remote Similarity NPD7838 Discovery
0.6897 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6897 Remote Similarity NPD5221 Approved
0.6897 Remote Similarity NPD5222 Approved
0.6891 Remote Similarity NPD4633 Approved
0.6891 Remote Similarity NPD5226 Approved
0.6891 Remote Similarity NPD5225 Approved
0.6891 Remote Similarity NPD5224 Approved
0.6889 Remote Similarity NPD6845 Suspended
0.6875 Remote Similarity NPD7100 Approved
0.6875 Remote Similarity NPD7101 Approved
0.6864 Remote Similarity NPD4700 Approved
0.6847 Remote Similarity NPD3618 Phase 1
0.6838 Remote Similarity NPD5173 Approved
0.6838 Remote Similarity NPD6084 Phase 2
0.6838 Remote Similarity NPD6083 Phase 2
0.6833 Remote Similarity NPD5174 Approved
0.6833 Remote Similarity NPD5175 Approved
0.6814 Remote Similarity NPD6101 Approved
0.6814 Remote Similarity NPD5764 Clinical (unspecified phase)
0.681 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6807 Remote Similarity NPD5223 Approved
0.6797 Remote Similarity NPD6335 Approved
0.6772 Remote Similarity NPD6868 Approved
0.6752 Remote Similarity NPD4697 Phase 3
0.6748 Remote Similarity NPD4729 Approved
0.6748 Remote Similarity NPD4730 Approved
0.6726 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6721 Remote Similarity NPD4767 Approved
0.6721 Remote Similarity NPD4768 Approved
0.6719 Remote Similarity NPD6317 Approved
0.6696 Remote Similarity NPD7334 Approved
0.6696 Remote Similarity NPD8035 Phase 2
0.6696 Remote Similarity NPD6684 Approved
0.6696 Remote Similarity NPD7521 Approved
0.6696 Remote Similarity NPD8034 Phase 2
0.6696 Remote Similarity NPD6409 Approved
0.6696 Remote Similarity NPD7146 Approved
0.6696 Remote Similarity NPD5330 Approved
0.6667 Remote Similarity NPD6314 Approved
0.6667 Remote Similarity NPD4786 Approved
0.6667 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6313 Approved
0.6641 Remote Similarity NPD6908 Approved
0.6641 Remote Similarity NPD6909 Approved
0.6641 Remote Similarity NPD6291 Clinical (unspecified phase)
0.664 Remote Similarity NPD5248 Approved
0.664 Remote Similarity NPD5251 Approved
0.664 Remote Similarity NPD5250 Approved
0.664 Remote Similarity NPD5247 Approved
0.664 Remote Similarity NPD5249 Phase 3
0.6639 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6638 Remote Similarity NPD4202 Approved
0.6636 Remote Similarity NPD3667 Approved
0.6613 Remote Similarity NPD5128 Approved
0.661 Remote Similarity NPD7839 Suspended
0.6607 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6579 Remote Similarity NPD6672 Approved
0.6579 Remote Similarity NPD6903 Approved
0.6579 Remote Similarity NPD5737 Approved
0.6571 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6557 Remote Similarity NPD4754 Approved
0.6552 Remote Similarity NPD7637 Suspended
0.6541 Remote Similarity NPD7830 Approved
0.6541 Remote Similarity NPD7829 Approved
0.6525 Remote Similarity NPD5695 Phase 3
0.6525 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6518 Remote Similarity NPD3665 Phase 1
0.6518 Remote Similarity NPD3666 Approved
0.6518 Remote Similarity NPD3133 Approved
0.65 Remote Similarity NPD5696 Approved
0.65 Remote Similarity NPD8387 Clinical (unspecified phase)
0.6491 Remote Similarity NPD7524 Approved
0.6466 Remote Similarity NPD5785 Approved
0.646 Remote Similarity NPD1733 Clinical (unspecified phase)
0.6457 Remote Similarity NPD5217 Approved
0.6457 Remote Similarity NPD5216 Approved
0.6457 Remote Similarity NPD5215 Approved
0.641 Remote Similarity NPD5693 Phase 1
0.6398 Remote Similarity NPD7799 Discontinued
0.6395 Remote Similarity NPD7625 Phase 1
0.6379 Remote Similarity NPD4753 Phase 2
0.6379 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6378 Remote Similarity NPD5134 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data